Literature DB >> 9886399

IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells.

K S Wang1, J Ritz, D A Frank.   

Abstract

IL-2 exerts potent but distinct functional effects on two critical cell populations of the immune system, T cells and NK cells. Whereas IL-2 leads to proliferation in both cell types, it enhances cytotoxicity primarily in NK cells. In both T cells and NK cells, IL-2 induces the activation of STAT1, STAT3, and STAT5. Given this similarity in intracellular signaling, the mechanism underlying the distinct response to IL-2 in T cells and NK cells is not clear. In this study, we show that in primary NK cells and NK cell lines, in addition to the activation of STAT1 and STAT5, IL-2 induces tyrosine phosphorylation of STAT4, a STAT previously reported to be activated only in response to IL-12 and IFN-alpha. This activation of STAT4 in response to IL-2 is not due to the autocrine production of IL-12 or IFN-alpha. STAT4 activated in response to IL-2 is able to bind to a STAT-binding DNA sequence, suggesting that in NK cells IL-2 is capable of activating target genes through phosphorylation of STAT4. IL-2 induces the activation of Jak2 uniquely in NK cells, which may underlie the ability of IL-2 to activate STAT4 only in these cells. Although the activation of STAT4 in response to IL-2 occurs in primary resting and activated NK cells, it does not occur in primary resting T cells or mitogen-activated T cells. The unique activation of the STAT4-signaling pathway in NK cells may underlie the distinct functional effect of IL-2 on this cell population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886399

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Jaks, STATs, Cytokines, and Sepsis.

Authors:  Melanie J Scott; Christopher J Godshall; William G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  CD28 is not directly involved in the response of human CD3- CD56+ natural killer cells to lipopolysaccharide: a role for T cells.

Authors:  M R Goodier; M Londei
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

3.  Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats.

Authors:  Ryan W Logan; Changqing Zhang; Sengottuvelan Murugan; Stephanie O'Connell; Dale Levitt; Alan M Rosenwasser; Dipak K Sarkar
Journal:  J Immunol       Date:  2012-02-03       Impact factor: 5.422

4.  Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade.

Authors:  Shane A Curran; Justin A Shyer; Erin T St Angelo; Lillian R Talbot; Sneh Sharma; David J Chung; Glenn Heller; Katharine C Hsu; Brian C Betts; James W Young
Journal:  Cancer Immunol Res       Date:  2016-12-06       Impact factor: 11.151

5.  IL-12Rβ2 is critical for survival of primary Francisella tularensis LVS infection.

Authors:  Amanda A Melillo; Oded Foreman; Karen L Elkins
Journal:  J Leukoc Biol       Date:  2013-02-25       Impact factor: 4.962

6.  STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis.

Authors:  C J Godshall; A B Lentsch; J C Peyton; M J Scott; W G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

7.  STAT4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation.

Authors:  Yanan S Zhang; Dazhuan E Xin; Zhizhang Wang; Xinyang Song; Yanyun Sun; Quanli C Zou; Jichen Yue; Chenxi Zhang; Junxun M Zhang; Zhi Liu; Xiaoren Zhang; Ting C Zhao; Bing Su; Y Eugene Chin
Journal:  EMBO J       Date:  2019-02-15       Impact factor: 11.598

Review 8.  STAT signaling in the pathogenesis and treatment of cancer.

Authors:  D A Frank
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

9.  Expansion of an atypical NK cell subset in mouse models of systemic lupus erythematosus.

Authors:  Elisaveta N Voynova; Jeffrey Skinner; Silvia Bolland
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

10.  Acquired STAT4 deficiency as a consequence of cancer chemotherapy.

Authors:  Ivan P Lupov; Larry Voiles; Ling Han; Allysia Schwartz; Manuel De La Rosa; Kinnari Oza; David Pelloso; Ravi P Sahu; Jeffrey B Travers; Michael J Robertson; Hua-Chen Chang
Journal:  Blood       Date:  2011-10-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.